Samuel Shakeson has been appointed as Pharmaceuticals Equities Analyst by Trinova Capital in Tokyo, Japan.
Trinova Capital, an independent equity research and alternative asset management firm, has today announced that Samuel Shakeson has joined the firm as a speciality pharmaceuticals equity research analyst.
"Samuel has been in the biopharmaceutical industry for over 20 years, primarily as a clinica...
